OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,474,043 | -36.5% | 2,061,797 | +4.4% | 1.48% | -33.8% |
| Q2 2023 | $10,189,953 | +1.0% | 1,974,797 | +3.2% | 2.23% | -10.6% |
| Q1 2023 | $10,084,735 | +93.7% | 1,913,612 | +3.3% | 2.49% | +67.1% |
| Q4 2022 | $5,206,775 | -46.0% | 1,852,945 | -20.3% | 1.49% | -37.0% |
| Q3 2022 | $9,643,000 | +15.9% | 2,323,673 | +12.3% | 2.37% | +21.4% |
| Q2 2022 | $8,319,000 | -19.1% | 2,069,313 | -0.3% | 1.95% | +11.1% |
| Q1 2022 | $10,278,000 | -29.6% | 2,076,313 | -0.9% | 1.76% | -26.2% |
| Q4 2021 | $14,604,000 | -32.1% | 2,095,313 | -2.5% | 2.38% | -26.7% |
| Q3 2021 | $21,493,000 | -30.1% | 2,149,313 | -0.8% | 3.24% | -23.3% |
| Q2 2021 | $30,732,000 | -10.7% | 2,167,313 | +3.4% | 4.23% | -17.5% |
| Q1 2021 | $34,401,000 | -23.4% | 2,096,341 | -3.3% | 5.13% | -25.4% |
| Q4 2020 | $44,889,000 | +138.6% | 2,168,573 | -12.3% | 6.87% | +104.2% |
| Q3 2020 | $18,812,000 | -3.1% | 2,472,067 | +6.1% | 3.36% | -17.2% |
| Q2 2020 | $19,411,000 | +89.1% | 2,330,267 | +12.4% | 4.06% | +43.2% |
| Q1 2020 | $10,265,000 | +22.4% | 2,073,719 | -2.3% | 2.84% | +66.9% |
| Q4 2019 | $8,386,000 | +37.3% | 2,123,058 | +5.7% | 1.70% | +10.7% |
| Q3 2019 | $6,106,000 | -2.0% | 2,008,484 | +41.8% | 1.54% | +12.5% |
| Q2 2019 | $6,231,000 | +90.3% | 1,416,247 | +71.7% | 1.36% | +90.6% |
| Q1 2019 | $3,274,000 | +13.5% | 824,747 | +13.8% | 0.72% | -10.1% |
| Q4 2018 | $2,885,000 | -32.4% | 724,747 | +16.9% | 0.80% | -2.9% |
| Q3 2018 | $4,266,000 | +18.6% | 619,945 | +16.3% | 0.82% | +12.8% |
| Q2 2018 | $3,598,000 | -5.7% | 532,986 | -9.1% | 0.73% | -4.6% |
| Q1 2018 | $3,816,000 | +300.4% | 586,239 | +173.6% | 0.76% | +292.8% |
| Q4 2017 | $953,000 | -50.2% | 214,239 | -30.8% | 0.19% | -50.0% |
| Q3 2017 | $1,914,000 | -41.3% | 309,707 | -12.0% | 0.39% | -41.9% |
| Q2 2017 | $3,258,000 | -12.1% | 351,850 | -11.9% | 0.67% | -11.8% |
| Q1 2017 | $3,705,000 | +284.7% | 399,200 | +247.1% | 0.76% | +236.4% |
| Q4 2016 | $963,000 | – | 115,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |